1. Home
  2. LGVN vs YOSH Comparison

LGVN vs YOSH Comparison

Compare LGVN & YOSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • YOSH
  • Stock Information
  • Founded
  • LGVN 2014
  • YOSH 2016
  • Country
  • LGVN United States
  • YOSH United States
  • Employees
  • LGVN N/A
  • YOSH N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • YOSH Restaurants
  • Sector
  • LGVN Health Care
  • YOSH Consumer Discretionary
  • Exchange
  • LGVN Nasdaq
  • YOSH Nasdaq
  • Market Cap
  • LGVN 23.4M
  • YOSH 23.7M
  • IPO Year
  • LGVN 2021
  • YOSH 2022
  • Fundamental
  • Price
  • LGVN $1.30
  • YOSH $9.40
  • Analyst Decision
  • LGVN Strong Buy
  • YOSH
  • Analyst Count
  • LGVN 3
  • YOSH 0
  • Target Price
  • LGVN $8.67
  • YOSH N/A
  • AVG Volume (30 Days)
  • LGVN 138.8K
  • YOSH 6.1K
  • Earning Date
  • LGVN 08-13-2025
  • YOSH 08-18-2025
  • Dividend Yield
  • LGVN N/A
  • YOSH N/A
  • EPS Growth
  • LGVN N/A
  • YOSH N/A
  • EPS
  • LGVN N/A
  • YOSH N/A
  • Revenue
  • LGVN $2,225,000.00
  • YOSH $13,539,317.00
  • Revenue This Year
  • LGVN N/A
  • YOSH N/A
  • Revenue Next Year
  • LGVN $51.48
  • YOSH N/A
  • P/E Ratio
  • LGVN N/A
  • YOSH N/A
  • Revenue Growth
  • LGVN 127.50
  • YOSH 41.82
  • 52 Week Low
  • LGVN $1.14
  • YOSH $2.71
  • 52 Week High
  • LGVN $6.40
  • YOSH $22.50
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 50.13
  • YOSH 30.44
  • Support Level
  • LGVN $1.15
  • YOSH $8.95
  • Resistance Level
  • LGVN $1.32
  • YOSH $14.31
  • Average True Range (ATR)
  • LGVN 0.09
  • YOSH 0.84
  • MACD
  • LGVN 0.01
  • YOSH -0.40
  • Stochastic Oscillator
  • LGVN 45.31
  • YOSH 8.46

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About YOSH Yoshiharu Global Co.

Yoshiharu Global Co is a restaurant operator. The company has one reportable segment, consisting of operating its stores. Yoshiharu serves the perfect, ideal ramen, as well as offers customers a wide variety of sushi, bento menus, and other favorite Japanese cuisines. It owns and operates restaurant stores.

Share on Social Networks: